Who Owns Alpha Brain? Onnit's Unilever Acquisition and What It Means for the Formula
Share
We've written before about who actually owns the supplement brands people assume are small and independent. Alpha Brain, Onnit's flagship nootropic, is one of the best examples in our own catalog — it's marketed with the same founder-story energy it had in 2010, but it's been owned by a $60B+ consumer goods conglomerate since 2021.
The actual ownership history
Onnit was founded by Aubrey Marcus in Austin, Texas in 2010, built largely on his own podcast and the Joe Rogan Experience's early sponsorship relationship. On April 27, 2021, Unilever announced an agreement to acquire Onnit, framing it as a move into the "holistic wellness and lifestyle" category; the deal closed on May 28, 2021 (Unilever, official press release, 2021). Marcus transitioned to a brand-ambassador role rather than an operating one, and Onnit continued operating out of Austin under CEO Jason Havey at the time of acquisition. As of this writing, Onnit remains part of Unilever's portfolio — we found no public record of a subsequent divestiture.
Does that change anything about the product?
Not the formula, as far as public evidence shows. Alpha Brain's core proprietary blends (Onnit calls them "Flow," "Focus," and "Fuel") — built around Alpha-GPC, Bacopa monnieri, Huperzine A, and L-theanine — predate the acquisition and remain the same blend structure post-acquisition. What acquisition by a company the size of Unilever typically does change is manufacturing scale, quality-system infrastructure, and distribution reach — none of which show up in a clinical evidence rubric, which is exactly why our scoring didn't move because of the ownership change. It moved because of a specific trial.
The evidence that actually matters: the Solomon 2016 RCT
Alpha Brain's real scientific credential is a randomized, double-blind, placebo-controlled trial testing the exact commercial formula sold at retail — not a generic ingredient review (Solomon TM, et al. "A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN administered orally." Hum Psychopharmacol Clin Exp. 2016;31(2):135-143). Sixty-three treatment-naive adults (18-35) completed a 2-week placebo run-in, then took Alpha Brain or placebo for 6 weeks. Result: significant improvement in delayed verbal recall and executive function versus placebo — but no improvement in attention, concentration, general learning/memory beyond delayed recall, or processing speed. It's a real, positive, targeted result, not the sweeping "boosts your brain" claim the marketing implies. Worth flagging in the interest of the same transparency this piece is about: the trial was industry-affiliated with Onnit, which doesn't invalidate the methodology but is relevant context when weighing it against fully independent research.
Why it's Verified, not Elite, on our rubric
When we rescored Onnit's products against this RCT, the brand-specific commercial-formula trial earned a real evidence uplift — the flagship SKU moved from 58 to 70/100. What's holding it below Elite is the same issue that caps most proprietary-blend products: Onnit discloses the total blend weight for "Flow," "Focus," and "Fuel" but not the individual milligram dose of each ingredient inside them. You can verify the blend was tested as a whole; you can't verify whether any single active ingredient in it is dosed at a clinically meaningful level on its own.
| Product | Score | Why |
|---|---|---|
| ONNIT Alpha Brain (90 Count) | 70 Verified | Solomon 2016 commercial-formula RCT uplift; capped by proprietary-blend dosing opacity |
| ONNIT Alpha Brain (90 Count, alt listing) | 68 Verified | Same formula, same evidence basis |
| Onnit Alpha BRAIN | 65 Verified | Same formula, same evidence basis |
| Alpha BRAIN® Cognitive Support | 58 Standard | Pre-rescore listing; same underlying product |
See the full ranked comparison of every scored cognitive health and nootropic supplement for how Alpha Brain stacks up against single-ingredient, fully-dosed alternatives.
Common questions
Did Unilever change the Alpha Brain formula after acquiring Onnit?
No public evidence of a formula change tied to the acquisition. The proprietary blend structure predates 2021 and remains the same post-acquisition.
Is Alpha Brain FDA approved?
No — and it couldn't be. Dietary supplements aren't FDA-approved for efficacy the way drugs are; the FDA only regulates manufacturing practices and prohibits false disease claims. Any marketing implying FDA approval of a supplement's effects is misleading by definition.
Is a bigger company a bad sign for a supplement brand?
Not inherently. Corporate ownership often brings better GMP infrastructure and quality control than a small operation can afford. What actually matters for our scoring is what it's always been: dose disclosure, evidence quality, manufacturing standards, and honest labeling — not who signs the checks at headquarters.
Why does the proprietary blend hurt the score if the RCT tested that exact blend?
The trial validates the blend as a whole works as tested. It doesn't tell you, for example, whether the Huperzine A dose inside "Focus" is at a level with its own independent evidence behind it, or whether it's present at a token amount. Full per-ingredient disclosure is what would let us verify that layer too.
The honest summary
- Onnit has been Unilever-owned since 2021 — the founder-story marketing predates that by over a decade
- The formula hasn't publicly changed as a result of the acquisition
- Alpha Brain has a real commercial-formula RCT (Solomon 2016) showing targeted, not sweeping, cognitive benefits
- Proprietary blend opacity is the actual ceiling on the score — not ownership structure
Next steps: